我司是一家具备国际一级货运代理公司，拥有雄厚的经济基础和强大的全球关系网络，完善的组织架构和人员配置，在国内外具有很好的口碑和信誉。同时，也与船东、港区、海关保持着较好的关系网络。以客户至上的经营理念，为客户提供周密专业的运输方案。

Aftermorethanthreedecadesofintenseeffortssince1976,K-Pro,withitspersistentbeliefinqualityistheonlyguaranteeofcustomers

三六常识

伍品网—全风险代理商标侵权、专利侵权、著作权侵权案件。#打赢官司再收费

该站点未添加描述description...

联合早报中国版，每天即时为身在中国的你提供新加坡、中国、东南亚、亚洲和国际新闻。从财经、体育、生活娱乐资讯到评论分析、应有尽有，帮助你掌握全球趋势。

多种草是一个专为自媒体博主、市场运营设计的AI智能创作平台，服务自媒体工作者在抖音、小红书、微信等全平台文案及图文撰写

交能网-做领先的电力市场与能源数据服务平台

轻客洗衣是一款智能洗衣应用，轻客团队致力于向广大学生、白领、蓝领等群体提供健康、实惠的优质洗衣服务，通过手机APP控制智能洗衣机的方式，为用户带来全新的智能洗衣体验。

诺博汽车专门致力于汽车座椅、内饰、汽车电子、外饰、橡胶产品的一级供应商。我们拥有广泛的产品组合及独立自主的研发能力，可谓客户提供安全、舒适、差异化的系统解决方案。

该站点未添加描述description...

WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.